| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
OKYO Pharma Limited (LSE: OKYO)
OKYO Technical Analysis
5
| As on 19th May 2023 OKYO STOCK Price closed @ 1.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.01 & Strong Sell for SHORT-TERM with Stoploss of 6.86 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OKYOSTOCK Price
| Open | 1.85 | Change | Price | % |
| High | 1.98 | 1 Day | -0.45 | -24.32 |
| Low | 1.40 | 1 Week | -0.70 | -33.33 |
| Close | 1.40 | 1 Month | -0.65 | -31.71 |
| Volume | 356506 | 1 Year | -5.35 | -79.26 |
| 52 Week High 8.50 | 52 Week Low 1.55 | ||||
LSE UK Most Active Stocks
| NTOG | 0.02 | 0.00% |
| CPX | 0.14 | 7.69% |
| MSMN | 0.04 | 0.00% |
| VELA | 0.01 | % |
| TRP | 0.03 | % |
| SCGL | 0.27 | 92.86% |
| DKE | 0.15 | 0.00% |
| NNN | 0.09 | 50.00% |
| DMTR | 0.03 | 0.00% |
| VAST | 0.08 | 14.29% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| OKYO Daily Charts |
OKYO Intraday Charts |
Whats New @ Bazaartrend |
OKYO Free Analysis |
|
|
OKYO Important Levels Intraday
| RESISTANCE | 2.52 |
| RESISTANCE | 2.16 |
| RESISTANCE | 1.94 |
| RESISTANCE | 1.72 |
| SUPPORT | 1.08 |
| SUPPORT | 0.86 |
| SUPPORT | 0.64 |
| SUPPORT | 0.28 |
OKYO Forecast November 2024
| 4th UP Forecast | 7.18 |
| 3rd UP Forecast | 5.33 |
| 2nd UP Forecast | 4.18 |
| 1st UP Forecast | 3.04 |
| 1st DOWN Forecast | -0.24 |
| 2nd DOWN Forecast | -1.38 |
| 3rd DOWN Forecast | -2.53 |
| 4th DOWN Forecast | -4.38 |
OKYO Weekly Forecast
| 4th UP Forecast | 3.10 |
| 3rd UP Forecast | 2.55 |
| 2nd UP Forecast | 2.22 |
| 1st UP Forecast | 1.88 |
| 1st DOWN Forecast | 0.92 |
| 2nd DOWN Forecast | 0.58 |
| 3rd DOWN Forecast | 0.25 |
| 4th DOWN Forecast | -0.30 |
OKYO Forecast2024
| 4th UP Forecast | 16.14 |
| 3rd UP Forecast | 11.41 |
| 2nd UP Forecast | 8.49 |
| 1st UP Forecast | 5.57 |
| 1st DOWN Forecast | -2.77 |
| 2nd DOWN Forecast | -5.69 |
| 3rd DOWN Forecast | -8.61 |
| 4th DOWN Forecast | -13.34 |
OKYO Pharma Limited ( LSE UK Symbol : OKYO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OKYO Business Profile
OKYO Pharma Limited operates as a preclinical biopharmaceutical company in the United Kingdom. Its preclinical development program includes OK-101 for the treatment of dry eyes, uveitis, and allergic conjunctivitis; and OK-201 to treat corneal neuropathic pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome (ARDS). OKYO Pharma Limited was incorporated in 2018 and is headquartered in London, the United Kingdom. Address: 55 Park Lane, London, United Kingdom, W1K 1NA
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service